Financials

  • Market Capitalization 396.63 M
  • Employee 120
  • Founded 1995
  • CEO N/A
  • Website www.enanta.com
  • Headquarter Massachusetts, United States
  • FIGI BBG001V9NSB4
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.12
Price to sales ratio
0

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3093
ABEO
Abeona Therapeutics Inc. - Common Stock
7.01 USD+0.43%+10.92%+26.53%+17.82%399.54 M USD
3101
IPSC
Century Therapeutics, Inc. - Common Stock
2.20 USD-2.22%-8.33%-5.58%+272.88%396.78 M USD
3109
AUTL
Autolus Therapeutics plc - American Depositary Shares
1.48 USD-8.07%-9.20%-8.64%-44.36%393.91 M USD
3121
LRMR
Larimar Therapeutics, Inc. - Common Stock
3.73 USD-12.85%+11.34%+6.27%+6.27%387.48 M USD

Frequently asked questions about Enanta Pharmaceuticals, Inc. - Common Stock

What is the Enanta Pharmaceuticals, Inc. - Common Stock stock price today?

The current price of Enanta Pharmaceuticals, Inc. - Common Stock (ENTA) is 13.64. Over the past 24 hours, the stock has changed by -0.44%. Follow the ENTA chart for real-time price dynamics.

What is the stock ticker of Enanta Pharmaceuticals, Inc. - Common Stock?

Enanta Pharmaceuticals, Inc. - Common Stock trades under the ticker ENTA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Enanta Pharmaceuticals, Inc. - Common Stock stock going up?

ENTA has changed by -6.96% over the last week, +14.14% over the last month, and +95.70% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Enanta Pharmaceuticals, Inc. - Common Stock net income for the last quarter?

Enanta Pharmaceuticals, Inc. - Common Stock reported net income of -13.09 M for the last quarter. The previous quarter showed -11.94 M, which means net income changed by -9.66%.

How many employees does Enanta Pharmaceuticals, Inc. - Common Stock have?

As of the latest available data, Enanta Pharmaceuticals, Inc. - Common Stock has 120 employees. Workforce size can provide additional context about the company's scale and operations.

What is Enanta Pharmaceuticals, Inc. - Common Stock EBITDA?

Enanta Pharmaceuticals, Inc. - Common Stock EBITDA is -11.55 M, and its EBITDA margin is -67.31%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Enanta Pharmaceuticals, Inc. - Common Stock stock?

You can buy Enanta Pharmaceuticals, Inc. - Common Stock (ENTA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Enanta Pharmaceuticals, Inc. - Common Stock stock?

Investing in Enanta Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ENTA chart and related analysis on metatrader.com as part of your research.

News